Operating from their laboratory facilities at the Vancouver Island Technology Park in Victoria, British Columbia … ImmunoPrecise is an 'end-to-end' provider for accelerated antibody research and discovery.
Investor deep dive
ImmunoPrecise Antibodies expecting significant revenue growth in 2019
ImmunoPrecise Antibodies on an aggressive sales and business development drive
Quick facts: ImmunoPrecise Antibodies Ltd
Market Cap: $40.08 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ImmunoPrecise Antibodies Ltd named herein, including the promotion by the Company of ImmunoPrecise Antibodies Ltd in any Content on the Site,...FOR OUR FULL DISCLAIMER CLICK HERE